Research progress of DYRK2 in tumor occurrence,development, and prognosis
CSTR:
Author:
Affiliation:

1.Department of Oncology,Nantong Tumor Hospital/Tumor Hospital Affiliated to Nantong University;2.Department of Pathophysiology,Medical School,Nantong University;3.Department of Pathology, Nantong Tumor Hospital/Tumor Hospital Affiliated to Nantong University

Clc Number:

R730.23

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Dual-specificity tyrosine-phosphorylation-regulated kinase 2(DYRK2) belongs to the DYRK family and is an evolutionarily conserved enzyme in eukaryotes. The expression of DYRK2 varies greatly in different tissues and tumors. Previous reports on the role of DYRK2 in tumors have shown that it can delay tumor growth by prolonging G1 phase,promoting apoptosis,and inhibiting epithelial-mesenchymal transition. Recent studies have found that DYRK2 can also play a cancer-promoting role by enhancing cell mitosis,tumor apoptosis resistance,cell invasion and migration,and drug resistance. Here we present a review of the structure and function of DYRK2 as well as its roles in tumor occurrence,development,and prognosis.

    Reference
    Related
    Cited by
Get Citation

Zhang Jie, Jiang Yijing, Wu Yaxun. Research progress of DYRK2 in tumor occurrence,development, and prognosis[J]. Journal of Chongqing Medical University,2023,48(11):1308-1313

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 18,2023
  • Revised:
  • Adopted:
  • Online: December 06,2023
  • Published:
Article QR Code